Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,040 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.
Petraitiene R, Petraitis V, Groll AH, Sein T, Schaufele RL, Francesconi A, Bacher J, Avila NA, Walsh TJ. Petraitiene R, et al. Among authors: walsh tj. Antimicrob Agents Chemother. 2002 Jan;46(1):12-23. doi: 10.1128/AAC.46.1.12-23.2002. Antimicrob Agents Chemother. 2002. PMID: 11751105 Free PMC article.
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V, Petraitiene R, Groll AH, Roussillon K, Hemmings M, Lyman CA, Sein T, Bacher J, Bekersky I, Walsh TJ. Petraitis V, et al. Among authors: walsh tj. Antimicrob Agents Chemother. 2002 Jun;46(6):1857-69. doi: 10.1128/AAC.46.6.1857-1869.2002. Antimicrob Agents Chemother. 2002. PMID: 12019101 Free PMC article.
Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton D, Ghannoum M, Sein T, Schaufele R, Peter J, Bacher J, Casler H, Armstrong D, Espinel-Ingroff A, Rinaldi MG, Lyman CA. Walsh TJ, et al. J Infect Dis. 2003 Jul 15;188(2):305-19. doi: 10.1086/377210. Epub 2003 Jul 9. J Infect Dis. 2003. PMID: 12854088
Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis.
O'Sullivan CE, Kasai M, Francesconi A, Petraitis V, Petraitiene R, Kelaher AM, Sarafandi AA, Walsh TJ. O'Sullivan CE, et al. Among authors: walsh tj. J Clin Microbiol. 2003 Dec;41(12):5676-82. doi: 10.1128/JCM.41.12.5676-5682.2003. J Clin Microbiol. 2003. PMID: 14662960 Free PMC article.
Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitiene R, Petraitis V, Lyman CA, Groll AH, Mickiene D, Peter J, Bacher J, Roussillon K, Hemmings M, Armstrong D, Avila NA, Walsh TJ. Petraitiene R, et al. Among authors: walsh tj. Antimicrob Agents Chemother. 2004 Apr;48(4):1188-96. doi: 10.1128/AAC.48.4.1188-1196.2004. Antimicrob Agents Chemother. 2004. PMID: 15047519 Free PMC article.
Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis.
Petraitis V, Petraitiene R, Lin P, Calis K, Kelaher AM, Muray HA, Mya-San C, Mickiene D, Bacher J, Walsh TJ. Petraitis V, et al. Among authors: walsh tj. Antimicrob Agents Chemother. 2005 Apr;49(4):1642-5. doi: 10.1128/AAC.49.4.1642-1645.2005. Antimicrob Agents Chemother. 2005. PMID: 15793161 Free PMC article.
1,040 results